Meeting
2020 Gastrointestinal Cancers Symposium
The adherence to The American Association for The Study of Liver Disease (AASLD) guidelines in treating patients with hepatocellular carcinoma: Institutional experience.
Authors
Ashish Manne
Medical Oncology, Mitchell Cancer Institute, The University of South Alabama, Mobile, AL
Ashish Manne , Daisy E. Escobar , Pranitha Prodduturvar , Phillip Henderson , Osama Abdul-Rahim , Zeiad Hussain , Spencer Liles , Annabelle Fonseca , John Harrison Howard , Wadad Mneimneh , Robert Gilbert , Sachin Gopalkrishna Pai , Moh'd M. Khushman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer
Track
Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 496)
Abstract #
496
Poster Bd #
A21
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
Stereotactic body radiotherapy for hepatocellular carcinoma in the setting of poor liver function: A case series.
First Author: Vladimir Valakh
First Author: Chi Leung Chiang
Poster
2022 ASCO Annual Meeting
Sequential trans-arterial chemoembolization and stereotactic body radiotherapy followed by immunotherapy (START-FIT) for locally advanced hepatocellular carcinoma: A single-arm, phase II trial.
First Author: Chi Leung Chiang
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Stereotactic body radiotherapy (SBRT) with functional treatment planning in patients with hepatocellular carcinoma (HCC) and advanced hepatic cirrhosis: Survival outcomes and toxicity.
First Author: Alexander V. Kirichenko